Tag: coinfection


  • DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained

    DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained

    Understanding the Context: HIV, HCV, and HCC Hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) coinfection pose unique health challenges. In the past decade, direct-acting antivirals (DAAs) transformed HCV treatment, offering high cure rates and improved liver outcomes. However, even after what appears to be a sustained virologic response or cure, researchers have…

  • DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    Hepatitis C, HIV, and the evolving role of DAAs Direct-acting antivirals (DAAs) have transformed hepatitis C virus (HCV) treatment, offering cure rates that were once unimaginable. For people living with both HIV and HCV, the landscape has been more complex. While DAAs effectively clear the hepatitis C infection, experts have long asked how this virologic…